William P. Sheridan - 27 May 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Chief Medical Officer
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
27 May 2021
Net transactions value
-$1,583,491
Form type
4
Filing time
01 Jun 2021, 16:33:12 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Options Exercise $118,056 +24,959 +172% $4.73 39,434 27 May 2021 Direct F1
transaction BCRX Common Stock Options Exercise $199,569 +35,701 +91% $5.59 75,135 27 May 2021 Direct F1
transaction BCRX Common Stock Options Exercise $60,490 +11,099 +15% $5.45 86,234 27 May 2021 Direct F1
transaction BCRX Common Stock Sale $1,076,385 -71,759 -83% $15.00 14,475 27 May 2021 Direct F1, F2
transaction BCRX Common Stock Options Exercise $102,234 +21,614 +149% $4.73 36,089 28 May 2021 Direct F1
transaction BCRX Common Stock Options Exercise $359,431 +64,299 +178% $5.59 100,388 28 May 2021 Direct F1
transaction BCRX Common Stock Options Exercise $32,160 +5,901 +5.9% $5.45 106,289 28 May 2021 Direct F1
transaction BCRX Common Stock Sale $1,379,046 -91,814 -86% $15.02 14,475 28 May 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -24,959 -54% $0.000000 21,614 27 May 2021 Common Stock 24,959 $4.73 Direct F1
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -35,701 -36% $0.000000 64,299 27 May 2021 Common Stock 35,701 $5.59 Direct F1
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -11,099 -65% $0.000000 5,901 27 May 2021 Common Stock 11,099 $5.45 Direct F1
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -21,614 -100% $0.000000* 0 28 May 2021 Common Stock 21,614 $4.73 Direct F1
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -64,299 -100% $0.000000* 0 28 May 2021 Common Stock 64,299 $5.59 Direct F1
transaction BCRX Emp. Stock Option (Right to Buy) Options Exercise $0 -5,901 -100% $0.000000* 0 28 May 2021 Common Stock 5,901 $5.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2020.
F2 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.00 to $15.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
F3 The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.00 to $15.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.